Early this week, Turing’s decision to raise the price of Daraprim from $13.50 a tablet to $750 was the subject of a New York Times story. The drug, which is generically known as pyrimethamine and was acquired by the company acquired in August, is used to treat a serious parasitic infection called toxoplasmosis, which can be life-threatening for those with compromised immune systems.
Shkreli said the new price will allow the company to break even or make a “small profit” on the drug. - FortuneGovernment intervention not required.
#Daraprim #PrescriptionDrugs
No comments:
Post a Comment